Stoke Therapeutics, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE4Stoke Therapeutics, Inc.STOKOct 2

   2 insider filings

   Barry Ticho, insider filing for STOK

   Show all 2

   • 4Insider filing for STOKOct 2
   • 4Insider filing for STOKOct 2

   Barry Ticho

2. ROUTINE144Stoke Therapeutics, Inc.STOKOct 2

   Stoke Therapeutics, Inc. - Allan Jonathan files Form 144

   • Filer CIK: 0001966716
   • Shares to be sold: 627
   • Date of sale: 10/02/2026

   Jonathan Allan

3. ROUTINESCHEDULE 13GStoke Therapeutics, Inc.STOKSep 30

   Ownership stake disclosure by BIOTECHNOLOGY VALUE FUND L P

   BIOTECHNOLOGY VALUE FUND L P, filed by

4. ROUTINE4Stoke Therapeutics, Inc.STOKSep 25

   2 insider filings

   Alexander Cumbo, insider filing for STOK

   Show all 2

   • 4Insider filing for STOKSep 25
   • 3New insider at STOKSep 25

   Alexander Cumbo, reporting

5. ROUTINE8-KStoke Therapeutics, Inc.STOKSep 25

   Current report

6. ROUTINE4Stoke Therapeutics, Inc.STOKSep 3

   Barry Ticho, insider filing for STOK

   Barry Ticho, reporting

7. ROUTINE4Stoke Therapeutics, Inc.STOKAug 18

   3 insider filings

   Barry Ticho, insider filing for STOK

   Show all 3

   • 4Insider filing for STOKAug 18
   • 4Insider filing for STOKAug 18
   • 4Insider filing for STOKAug 18

   Barry Ticho, reporting

8. ROUTINESCHEDULE 13G/AStoke Therapeutics, Inc.STOKAug 14

   Ownership stake disclosure by Lynx1 Capital Management LP (amended)

   Lynx1 Capital Management LP, filed by

9. ROUTINESCHEDULE 13G/AStoke Therapeutics, Inc.STOKAug 12

   Ownership stake disclosure by TORONTO DOMINION BANK (amended)

   TORONTO DOMINION BANK, filed by

10. ROUTINESCHEDULE 13G/AStoke Therapeutics, Inc.STOKAug 6

    Ownership stake disclosure by FMR LLC (amended)

    FMR LLC, filed by

11. ROUTINE4Stoke Therapeutics, Inc.STOKAug 5

    Barry Ticho, insider filing for STOK

    Barry Ticho, reporting

12. ROUTINE8-KStoke Therapeutics, Inc.STOKAug 3

    Current report

13. ROUTINE424B5Stoke Therapeutics, Inc.STOKAug 3

    Securities offering

14. ROUTINE144Stoke Therapeutics, Inc.STOKAug 3

    Barry Ticho, planned sale of STOK shares

    Barry Ticho, reporting

15. ROUTINES-8Stoke Therapeutics, Inc.STOKAug 3

    Employee stock plan registration

16. NOTABLE10-QStoke Therapeutics, Inc.STOKAug 3

    Quarterly report

17. ROUTINE8-KStoke Therapeutics, Inc.STOKAug 3

    Current report

18. ROUTINE4Stoke Therapeutics, Inc.STOKJul 17

    3 insider filings

    Seth Loring Harrison, insider filing for STOK

    Show all 3

    • 4Insider filing for STOKJul 17
    • 4Insider filing for STOKJul 17
    • 3New insider at STOKJul 17

    Seth Loring Harrison, reporting

19. ROUTINE4Stoke Therapeutics, Inc.STOKJul 6

    Barry Ticho, insider filing for STOK

    Barry Ticho, reporting

20. ROUTINE144Stoke Therapeutics, Inc.STOKJul 1

    Barry Ticho, planned sale of STOK shares

    Barry Ticho, reporting

21. ROUTINE8-KStoke Therapeutics, Inc.STOKJun 30

    Current report

22. ROUTINE4Stoke Therapeutics, Inc.STOKJun 18

    Jonathan Allan, insider filing for STOK

    Jonathan Allan, reporting

23. ROUTINE144Stoke Therapeutics, Inc.STOKJun 16

    Jonathan Allan, planned sale of STOK shares

    Jonathan Allan, reporting

24. ROUTINE4Stoke Therapeutics, Inc.STOKJun 5

    7 insider filings

    Arthur Tzianabos, insider filing for STOK

    Show all 7

    • 4Insider filing for STOKJun 5
    • 4Insider filing for STOKJun 5
    • 4Insider filing for STOKJun 5
    • 4Insider filing for STOKJun 5
    • 4Insider filing for STOKJun 5
    • 4Insider filing for STOKJun 5
    • 4Insider filing for STOKJun 5

    Arthur Tzianabos, reporting

25. ROUTINE8-KStoke Therapeutics, Inc.STOKJun 4

    Current report

26. ROUTINE4Stoke Therapeutics, Inc.STOKJun 3

    Barry Ticho, insider filing for STOK

    Barry Ticho, reporting

27. ROUTINESCHEDULE 13G/AStoke Therapeutics, Inc.STOKMay 18

    Ownership stake disclosure by Lynx1 Capital Management LP (amended)

    Lynx1 Capital Management LP, filed by

28. ROUTINESCHEDULE 13G/AStoke Therapeutics, Inc.STOKMay 15

    2 13G filings

    Ownership stake disclosure by Lynx1 Capital Management LP (amended)

    Show all 2

    • SCHEDULE 13G/AOwnership stake disclosure (amended)May 15
    • SCHEDULE 13G/AOwnership stake disclosure (amended)May 15

    Lynx1 Capital Management LP, filed by

29. ROUTINESCHEDULE 13G/AStoke Therapeutics, Inc.STOKMay 15

    Ownership stake disclosure by TORONTO DOMINION BANK (amended)

    TORONTO DOMINION BANK, filed by

30. ROUTINESCHEDULE 13G/AStoke Therapeutics, Inc.STOKMay 15

    Ownership stake disclosure by RTW INVESTMENTS, LP (amended)

    RTW INVESTMENTS, LP, filed by

31. ROUTINESCHEDULE 13GStoke Therapeutics, Inc.STOKMay 15

    Ownership stake disclosure by WELLINGTON MANAGEMENT GROUP LLP

    WELLINGTON MANAGEMENT GROUP LLP, filed by

32. ROUTINE8-KStoke Therapeutics, Inc.STOKMay 7

    Current report

33. NOTABLE10-QStoke Therapeutics, Inc.STOKMay 7

    Quarterly report

34. ROUTINE4Stoke Therapeutics, Inc.STOKMay 5

    Barry Ticho, insider filing for STOK

    Barry Ticho, reporting

35. ROUTINE144Stoke Therapeutics, Inc.STOKMay 1

    Barry Ticho, planned sale of STOK shares

    Barry Ticho, reporting

36. ROUTINEARSStoke Therapeutics, Inc.STOKApr 22

    Annual report to shareholders

37. ROUTINEDEFA14AStoke Therapeutics, Inc.STOKApr 22

    Additional proxy materials

Older filings on EDGAR